CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies

September 17, 2014 12:40 PM

13 0

Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens

WOONSOCKET, R.I., Sept. 17, 2014 /PRNewswire/ -- An analysis done by the CVS Health Research Institute provides insights regarding patients taking Sovaldi® (sofosbuvir), a new and expensive treatment for Hepatitis C introduced in December. The data shows that over the last several months (May throug...

Read more

To category page